Metal-based anticancer drugs are among the most successful therapeutic agents, as evidenced by the frequent prescription of
selected platinum and arsenic compounds to patients. Metal-based Anticancer Agents covers the interdisciplinary world of inorganic
drug discovery and development by introducing the most prominent compound classes based on different transition metals, discussing
emerging concepts and enabling methods, as well as presenting key pre-clinical and clinical aspects. Recent progress on the
unique features of next-generation targeted metal-based anticancer agents, including supramolecular coordination complexes
used for both therapy and drug delivery, promise a bright future beyond the benefits of pure cytotoxic activity. With contributions
from global leaders in the field, this book will serve as a useful reference to established researchers as well as a practical
guide to those new to metallodrugs, and postgraduate students of medicinal chemistry and metallobiology.